Numerous reports describing the influence of artificial amino acid side chains containing one, few, or several fluorine atoms on various peptide/protein properties have provided insights into the unpredictable ways in which this unique element engages in intermolecular interactions within protein environments.^[@ref1]^ We recently reported that P1 position mutants of the protease inhibitor BPTI containing either (2*S*)-4,4-difluoroethylglycine (DfeGly) or (2*S*)-4,4,4-trifluoroethylglycine (TfeGly) exhibit wild-type level inhibitor activity against β-trypsin, whereas the hydrocarbon parent BPTI containing (2*S*)-ethylglycine ((2*S*)-2-aminobutanoic acid (Abu)) is markedly less effective at inhibiting this enzyme.^[@ref2]^ In the protein environment of an enzyme active site, crystal structures supported a role for the fluorinated side chains in which multipolar interactions with protein amide fragments and a potential weak hydrogen bond to a structural water dominate. This is of course a very different kind of behavior than that observed, for example, by Marsh and co-workers in the environment of the hydrophobic core of a helical bundle; here, enhanced thermostability mediated by fluorine was based on increased buried hydrophobic surface area and volume.^[@ref3]^ In another recent study using DfeGly and TfeGly, we showed that side chain fluorination has differential effects on the protease stability of a model peptide substrate depending upon the number of fluorine atoms, the position of the unnatural amino acid, and the particular enzyme studied.^[@ref4]^

The studies described above were made possible by chemical synthesis of the fluorinated building blocks DfeGly and TfeGly, followed by automated solid-phase peptide synthesis (SPPS). However, this method has limitations with respect to the length of the polypeptide that can be synthesized. Thus, ribosomal synthesis would be a valuable tool for the synthesis of large proteins containing such artificial residues.

Ribosomal polypeptide synthesis is mediated by aminoacyl-tRNA synthetases (AARSs). These central enzymes in protein synthesis have been shown to be often unable to discriminate between sterically and biophysically similar canonical (cAAs, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b, left) and noncanonical (ncAAs, [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b, right) amino acids.^[@ref5]^ Thus, DfeGly and TfeGly have the potential to be accepted by the natural translation apparatus due to their similar calculated van der Waals volume and hydrophobicity compared to the natural substrates Ile, Leu, Val, and Met.^[@ref6]^ AARSs display a conserved mechanism of catalysis ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a, Aminoacylation).^[@ref7]^ First, they use the energy stored in ATP to activate the amino acid (AA), forming an aminoacyl-adenylate intermediate (AARS--AA-AMP) ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a, AA activation). In the second step, the AA is transferred to its corresponding tRNA ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a, AA transfer to tRNA). At the end of this process the charged tRNA dissociates to solution ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a, AA-tRNA dissociation from AARS) and can take part in translation at the ribosome. Fidelity of ribosomal peptide synthesis highly depends on the ability of AARSs to discriminate efficiently against noncognate AAs ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b). Some AARS families are unable to distinguish cognate ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b, left) from noncognate AAs in the aminoacylation reaction ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a, aminoacylation) alone. These enzymes possess additional editing activities in order to hydrolyze erroneously activated amino acids and misacylated tRNAs ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a, hydrolytic editing).^[@ref8]^

![(a) Overall kinetic scheme for hydrolytic editing by AARSs. Additionally, nonenzymatic editing is possible by release of the reaction intermediates and their hydrolysis free in solution. (b) Nomenclature used in this work for referring to amino acids.](oc-2016-003399_0001){#fig1}

In order to enhance translation of noncanonical amino acids several approaches were taken. One is to alter the substrate specificity by reengineering of the AARSs binding pockets. Successful examples comprise incorporations of 3-iodophenylalanine, 3-chlorophenylalanine and 3-bromophenylalanie and 3-iodotyrosine by engineered PheRS and TyRS, respectively.^[@ref9]−[@ref12]^ Oki et al. further increased the substrate specificity of the engineered TyrRS toward 3-iodotyrosine by transplantation of the PheRS editing domain, which prevents translation of Tyr.^[@ref13]^ Finally, the use of screening systems in combination with rational or computational design of binding and editing domain libraries of the AARSs has highly increased the number and selectivity of ncAA translations.^[@ref14]^

No evolutionary pressure existed for the discrimination of AARSs against artificial AAs ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b, right (i)), to which DfeGly and TfeGly belong, because they were not encountered by the enzymes during evolution. Because of the lack of comprehensive studies, little is known about the possible proofreading activity of AARSs against such building blocks.

In all class I AARSs, the Rossmann fold that comprises the catalytic domain is split by an inserted α/β domain (connective peptide 1, CP1). CP1 is greatly enlarged in IleRS, ValRS, and LeuRS, generating a distinct catalytic site for the hydrolysis of misacylated tRNAs ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a, post-transfer editing).^[@ref8],[@ref15]^ It has been proposed that this dedicated editing site acts as a second sieve that rejects noncognate AAs on the basis of steric issues and/or different hydrophobicity.^[@ref16]−[@ref20]^ Although the emerging evidence indicates that the mechanism is more complicated,^[@ref21],[@ref22]^ post-transfer editing undoubtedly acts as a powerful second check that prevents stable aminoacylation of tRNAs with noncognate AAs. In ILVRSs (IleRS, LeuRS, ValRS) the synthetic and editing sites are approximately 30--40 Å away from each other.^[@ref8]^ The AA covalently bound to tRNA is transferred for proofreading from the synthetic to the editing site by translocation of the 3′-end of AA-tRNA.^[@ref8]^ Besides post-transfer editing, AARSs may also employ pretransfer editing ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a) within the synthetic site.^[@ref8]^ In tRNA-independent pretransfer editing, noncognate aminoacyl-adenylate intermediates are hydrolyzed independently of the presence of tRNA.^[@ref23]^ In some cases, like in IleRS, tRNA may induce a conformational change that organizes the synthetic site for enhanced editing (tRNA-dependent pretransfer editing ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a)).^[@ref8],[@ref24]^ The contribution of each pathway to overall editing differs among various enzymes; for ILVRSs post-transfer editing represents the major pathway.^[@ref8]^

Disabling of ILVRS post-transfer editing has been shown to allow the translation of several ncAAs that are efficiently discriminated against by the wild-type enzymes. Different working groups have used rational site-directed mutagenesis of the editing domain or random mutagenesis in combination with a selection system to identify LeuRS and ValRS variants, respectively, that enabled the incorporation of numerous aliphatic ncAAs.^[@ref25]−[@ref28]^ Furthermore, Pezo et al. demonstrated that disruption of the editing site in IleRS by substituting 10 residues in the post-transfer editing domain with alanine leads to a mutant (IleRSAla10) that facilitates the ribosomal translation of norvaline, *O*-methylserine, norleucine, *S*-methylcysteine, and *O*-methylthreonine.^[@ref29]^

Interestingly, in none of these reports was the observation made that the crosstalk between synthetic and editing pathways of ncAAs differs from that of the 20 cAAs, and this may be true for side chains containing only elements from the cAA pool that were encountered by the AARSs during evolution. However, fluorine is absent from this pool and has unique stereoelectronic properties that arise from a combination of small size, very low polarizability, and the strongest inductive effect found among all the chemical elements^[@ref30]^ and consequentially might affect interactions and chemical steps mediated by AARSs in ways that have not yet been observed. Therefore, we sought to probe the compatibility of several aliphatic fluorinated amino acids with the natural ribosomal translation machinery by investigating the aminoacylation and editing activities of the AARSs against them, as well as their translation into polypeptides.

Results and Discussion {#sec2}
======================

Synthetic Active Site of ValRS and in Particular IleRS Shows Relaxed Substrate Tolerance toward the Selected Fluorinated AAs {#sec2.1}
----------------------------------------------------------------------------------------------------------------------------

Investigating the first step of aminoacylation ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a, AA activation) delivers important information about the likelihood of ribosomal translation of noncognate AAs. Activation of a specific substrate by an AARS is based on optimal binding at the ground and transition state, which can be investigated by Michaelis--Menten kinetic experiments. Both states are strongly influenced by the steric size and physicochemical properties of the AA substrate.^[@ref18],[@ref31]^ The parameter , which is the of the noncognate substrate divided by of the cognate substrate is often used to show how efficiently the noncognate substrate is utilized compared to the natural one; thus, a represents a substrate that is as good as the cognate one. In the absence of editing, a strong correlation between AA activation and ribosomal translation can be assumed.

However, this correlation might, besides editing, be further complicated by other steps of aminoacylation ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a), or arise from weaker or stronger binding to elongation factor (EF-Tu in prokaryotes like *Escherichiacoli* (*E. coli*)) or perturbed interactions at the ribosome.

The determined values for the activation of various fluorinated AAs ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a) by the different class Ia AARSs from *E. coli* (IleRS, ValRS, MetRS, LeuRS) are shown in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}b. The higher the bar in the figure, the larger the, and better the activation of the fluorinated AAs by a certain AARS compared to its cognate cAA. Additionally, this is represented by a color code: green, cyan, and yellow indicate a relatively good substrate, whereas black and red indicate only marginal or no observed activation. [Table S1](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf) shows the detailed kinetic values. On the basis of these results, among the class Ia AARSs, only ValRS and IleRS efficiently activate some selected fluorinated amino acids that have a different carbon backbone and structure than their cognate substrates (IleRS: MfeGly, DfeGly, TfeGly, (2*S*,3*R*)-TfVal; ValRS: MfeGly, TfeGly). We have investigated the crystal structures of the AARSs that exist in the PDB (Supporting Information, [Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)). From our analysis we conclude that this relaxed substrate tolerance of ValRS and IleRS is connected to the arrangement of the surface of the hydrophobic binding pockets of the enzymes, which, in the cases of MetRS and LeuRS reflect the shape of their cognate substrates, but in the cases of IleRS and ValRS the pockets display not high shape complementarity but rather a general hydrophobic cavity (Supporting Information, [Section 1.2, Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)). In the case of MetRS a particularly important determinant for its highly discriminating synthetic active site is the induced-fit mechanism of its binding pocket, as described by Serre et al.,^[@ref32]^ which differs from the preformed binding pockets of IleRS, ValRS, and LeuRS.

![(a) Chemical structure of natural substrates of class Ia AARSs and putative fluorinated analogues. 1: (2*S*)-4,4,4-trifluoroethylglycine (TfeGly), 2: (2*S*)-4,4-difluoroethylglycine (DfeGly), 3: (2*S*)-4-monofluoroethylglycine (MfeGly), 4: (2*S*)-4,4-difluoropropylglycine (DfpGly), 5: (2*S*,4*S*,4*R*)-5,5,5-trifluoroleucine (TfLeu), 6: (2*S*)-5,5,5,5′,5′,5′-hexafluoroleucine (HfLeu), 7: (2*S*,2*R*)-3,3,3-trifluoroalanine (TfAla), 8: (2*S*,3*R*)-4,4,4-trifluorovaline ((2*S*,3*R*)-TfVal), 9: (2*S*,3*S*)-4,4,4-trifluorovaline ((2*S*,3*S*)-TfVal), 10: (2*S*,2*R*)-4,4,4,4′,4′,4′-hexafluorovaline (HfVal), 11: (2*S*,2*R*)-6,6,6-trifluoronorleucine (TfNLeu), (b) Kinetic data that were determined in this study for the activation of these fluorinated AAs by the indicated class Ia AARSs.](oc-2016-003399_0002){#fig2}

Altogether, the activation rates of the fluorinated AAs by IleRS, LeuRS, and ValRS range from several hundred- to several thousand-fold lower than the values of the respective natural substrates ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, [Table S1](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)). These values clearly show that the fluorinated AAs are markedly less suitable substrates for the AARSs than their natural substrates. These activation data are in good agreement with previous reports^[@ref33]−[@ref38]^ of detailed kinetic studies for the activation of (2*S*,3*R*)-TfVal by ValRS and IleRS, and TfLeu and HfLeu by LeuRS as well as their effective ribosomal translation. The values are in a similar range compared to new amino acid activations (MfeGly, DfeGly, TfeGly) that we discovered in this study ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, [Table S1](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)). This suggests that they could be efficiently translated using the natural translation machinery in the absence of the cognate AARS substrate, i.e., in an appropriate auxotrophic genetic background; if such an attempt proved inefficient, supplementation of a vector that encodes the appropriate AARS gene, and would thus increase the amount of this biocatalyst in the cell, could improve the outcome.^[@ref34]^

Discovery and Investigation of Editing Function of IleRS against TfeGly {#sec2.2}
-----------------------------------------------------------------------

We chose TfeGly as a model artificial AA in order to probe ribosomal incorporation via IleRS. However, despite detected activation with IleRS ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, [Table S1](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)) no incorporation of TfeGly is observed in an Ile auxotrophic strain with TfeGly supplementation in the presence of increased cytosolic concentrations of IleRS (see Supporting Information, [Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)). A possible reason for this observation is that TfeGly is edited by IleRS ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a, hydrolytic editing).

To address this issue, we investigated in vitro the proofreading and two-step aminoacylation of TfeGly by *E. coli* IleRS. A substantial increase in TfeGly-dependent AMP accumulation clearly demonstrates that this artificial AA is edited by the wild-type enzyme ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a,b). The overall editing of TfeGly by IleRS is 100-fold reduced relative to the cAA valine (0.015 s^--1^ vs 1.56 s^--1^ for Val).^[@ref39]^ Nevertheless, this activity prevents stable formation of TfeGly-tRNA^Ile^, as confirmed in an independent assay that used \[^32^P\]-labeled tRNA ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}d). Our data ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}; Supporting Information, [Section 1.7](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)) further indicate that editing against TfeGly, the fluorinated synthetic Abu derivative, is significantly lower than editing of Abu, which is a natural ncAA^[@ref40],[@ref41]^ that is edited with an efficiency similar to canonical noncognate substrates.^[@ref27],[@ref42]−[@ref46]^

![Editing and aminoacylation of TfeGly by wild-type IleRS (wt) and IleRSAla10 (10Ala): (a) AMP formation by 2 μM enzyme in the presence of 20 mM [dl]{.smallcaps}-TfeGly and in the absence of tRNA^Ile^; (b) AMP formation by 2 μM enzyme in the presence of 20 mM [dl]{.smallcaps}-TfeGly and 10 μM tRNA^Ile^; (c) single-turnover deacylation of preformed TfeGly-tRNA^Ile^ using 10 μM enzyme or no enzyme (nonenzymatic); (d) aminoacylation of tRNA^Ile^ with [dl]{.smallcaps}-TfeGly in the presence of 1 μM enzyme.](oc-2016-003399_0003){#fig3}

Kinetic analysis demonstrates that IleRS edits TfeGly via a tRNA-independent route ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a) in a manner similar to valine.^[@ref39]^ Post-transfer editing can be measured independently of overall editing as enzyme deacylation activity against the preformed misacylated tRNA. Using this assay under single-turnover conditions (excess enzyme), we were able to show that IleRS also deacylates TfeGly-tRNA^Ile^ ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}c), yet with a rate that is 1300-fold slower than that reported^[@ref24]^ for Val-tRNA^Ile^ (0.048 s^--1^ for TfeGly-tRNA^Ile^ and 64 s^--1^ for Val-tRNA^Ile^).

To measure the contribution of post-transfer editing to TfeGly proofreading, IleRSAla10 (Supporting Information, [Section 1.5](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)), previously reported^[@ref29]^ as a post-transfer editing inactive mutant, was produced and kinetically characterized (Supporting Information, [Section 1.7](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)). We confirmed a complete loss of TfeGly-tRNA^Ile^ deacylation activity in this variant ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}c), justifying its further use in this analysis. As expected tRNA-independent editing, located in the synthetic site, is not significantly disturbed ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}a). Importantly, IleRSAla10 charges tRNA^Ile^ with TfeGly ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}d), confirming that post-transfer editing prevents TfeGly-tRNA^Ile^ accumulation by the wild-type enzyme. Independently measured transfer of TfeGly to tRNA^Ile^ yields a value of 0.5 s^--1^ or higher, which is about 10-fold lower than that of the cognate AA Ile (Supporting Information, [Figure S8](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)). Kinetic analysis thus provides evidence that TfeGly is not well discriminated at the level of *k*~cat~ (Supporting Information, [Table S1](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)) and *k*~trans~ in the IleRS synthetic pathway.

It has been shown that the highly conserved aspartate (Asp 342 in *E. coli* IleRS) forms a salt bridge with the α-NH~3~^+^ group of the AA attached to tRNA, acting as the main determinant of the IleRS post-transfer editing site.^[@ref47]^ Its substitution with alanine abolishes hydrolysis of Val-tRNA^Ile^.^[@ref24],[@ref48]^ To address the determinants of TfeGly editing, we measured deacylation of TfeGly-tRNA^Ile^ by IleRS D342A under single-turnover conditions. Interestingly, the mutant exhibits the same activity as the wild-type enzyme, showing that D342 does not significantly participate in the post-transfer editing of TfeGly (Supporting Information, [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)). Steric constraints imposed by the structurally distinct side chain may promote distinct positioning of TfeGly-tRNA^Ile^ in the editing site. This may be further facilitated by abrogation of the "anchoring" salt bridge due to the electron withdrawing effect of the CF~3~ group, which decreases the p*K*~a~ value of the α-NH~3~^+^ group of TfeGly.^[@ref49]^ Our finding thus supports the notion that AARS proofreading of artificial AAs may rely on different active site determinants compared to cAAs.

Wild-type IleRS does not accumulate TfeGly-tRNA^Ile^ ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}d), despite the fast synthetic steps and slow deacylation of TfeGly-tRNA^Ile^. This was intriguing because the measured rate of deacylation was actually at the level of post-transfer editing of the cognate Ile-tRNA^Ile^ (0.058 s^--1^),^[@ref24]^ which evades editing and readily accumulates in solution. We have previously^[@ref50]^ shown that the fate of aminoacylated tRNA is determined by its kinetic partitioning between dissociation from the enzyme and deacylation at the editing domain ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). In the case of TfeGly-tRNA^Ile^, slow deacylation is still kinetically favored, presumably due to reduced efficiency of the dissociation step.

![Kinetic partitioning of IleRS post-transfer proofreading. The values for both processes (dissociation and hydrolysis) obtained for TfeGly-tRNA^Ile^ in this study are compared with values of our previous studies with IleRS and Ile-tRNA^Ile^ and Val-tRNA^Ile^.^[@ref24],[@ref51]^](oc-2016-003399_0004){#fig4}

In contrast to TfeGly, the cognate product readily accumulates in solution, because kinetic partitioning of Ile-tRNA^Ile^ is poised to favor product dissociation. The presumed slow dissociation of TfeGly-tRNA^Ile^ from the enzyme is further supported with the observed slow TfeGly-tRNA^Ile^ accumulation by IleRSAla10. This variant activates TfeGly (0.3 s^--1^) and transfers it to tRNA^Ile^ (0.5 s^--1^) with rates that are significantly faster than the steady-state rate of its misaminoacylation (0.002 s^--1^; [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}d). This suggests that product (TfeGly-tRNA) dissociation is the rate-limiting step, and its rate may be approximated by the misaminoacylation rate.

To further address this issue, we introduced another substitution, T243R, in the background of D342A IleRS. The rationale was to reverse a kinetic partitioning of TfeGly-tRNA^Ile^ by a mutation that may promote the dissociation step. We assumed that slow post-transfer editing of TfeGly-tRNA would not be able to prevent its accumulation in this case, as it could be outcompeted by more rapid TfeGly-tRNA^Ile^ dissociation step. We have previously shown that the T243R substitution lowers affinity of the enzyme for Val-tRNA^Ile^.^[@ref39]^ Therefore, we produced the T243R/D342A variant and showed that it significantly accumulates TfeGly-tRNA^Ile^ ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}a,b) as anticipated. Separately tested post-transfer editing of this mutant showed a deacylation rate of TfeGly-tRNA (*k*~deacy~ = 0.047 s^--1^; Supporting Information, [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)) equal to that of the wild-type enzyme, which does not accumulate TfeGly-tRNA^Ile^. This confirms that TfeGly-tRNA^Ile^ evades active T243R/D342A editing, because of its enhanced dissociation. The misacylated tRNAs that have escaped editing in cis (operating via translocation of the 3′-end of the AA-tRNA from the synthetic to the editing site) may however rebind the enzyme from solution for editing in trans.^[@ref52]^ To analyze distribution of TfeGly-tRNA^Ile^ between the enzyme-free and enzyme-bound forms, activated EF-Tu was added to the misaminoacylation mixture of T243R/D342A. EF-Tu--TfeGly-tRNA^Ile^ complex formation shifted the equilibrium toward the enzyme-free form and promoted misacylation ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}a,b). In another experiment, we followed misaminoacylation using a higher concentration of T243R/D342A (5 μM) to promote association of TfeGly-tRNA^Ile^ with the enzyme and editing ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}d). No misaminoacylated tRNA was detected under these conditions ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}d). This confirms that T243R/D342A opposite behavior relative to the wild-type enzyme is a consequence of reversed kinetic partitioning that favors TfeGly-tRNA^Ile^ dissociation. Similarly, EF-Tu does not show any significant effect on the rate or plateau of TfeGly-tRNA formation by wild-type IleRS or any of the single mutants ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}c). T243R IleRS performs all reactions with TfeGly equally to the wild-type enzyme (Supporting Information, [Table S2](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)).

![(a and b) Misaminoacylation of tRNA^Ile^ with TfeGly by 1 μM T243R/D342A IleRS in the presence or absence of activated EF-Tu on different time scales. (c) Misaminoacylation of tRNA^Ile^ with TfeGly by 2 μM wild-type IleRS in the presence or absence of activated EF-Tu. (d) Misaminoacylation and AMP formation by 5 μM T243R/D342A IleRS in the presence of TfeGly.](oc-2016-003399_0005){#fig5}

The presented data support a model wherein kinetic partitioning of aminoacylated tRNA ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}) dictates the contribution of synthetic and editing pathways. In general, rapid editing of noncognate AAs outcompetes dissociation of the respective misacylated tRNAs, while the opposite is true for the cognate systems; i.e., editing here is significantly slower than AA-tRNA dissociation. Perturbation of the partitioning of aminoacylated tRNAs, introduced by a protein mutation (Cvetesic et al.^[@ref50]^), or by a novel chemical feature of the artificial AA substrate (this work), may significantly influence misaminoacylation activity of the enzyme. Here we show that the unique stereoelectronic properties of fluorine govern distinct TfeGly-tRNA^Ile^ partitioning within the editing site, permitting the weak AA-tRNA deacylation activity to functionally contribute to protein quality control.

In Vivo Translation of TfeGly with Post-Transfer Inactive IleRS {#sec2.3}
---------------------------------------------------------------

In the previous section we discussed that wild-type IleRS hydrolyzes TfeGly-tRNA^Ile^, which prevents TfeGly from being translated in the place of Ile in vivo. Our experiments show that the mutant IleRSAla10 is totally defective in post-transfer editing and thus accumulates TfeGly-tRNA^Ile^ in vitro. Therefore, we further tested both the wild-type and this mutant for their in vivo translation of TfeGly into our model peptide VW18Ile^[@ref53]^ (Supporting Information, [Section 1.3](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)) that was expressed in the absence of Ile and in the presence of 1 mM TfeGly.

Using this approach, we detected ribosomal translation of TfeGly in place of Ile only in the presence of the post-transfer inactive IleRS mutant ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). To the best of our knowledge, this is the first report of successful ribosomal translation of TfeGly. We also tested several other fluorinated amino acids. We detected an increase in the rate of aminoacylation and in vivo misincorporation of TfNVal using IleRSAla10 relative to the wild-type enzyme (Supporting Information, [Figures S6 and S7](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)). This indicates that TfNVal influences the partitioning of AA-tRNA in a manner similar to TfeGly, making inactivation of post-transfer editing important for its efficient misacylation. We did not observe this effect with TfIle and TfVal (Supporting Information, [Figures S6 and S7](http://pubs.acs.org/doi/suppl/10.1021/acscentsci.6b00339/suppl_file/oc6b00339_si_001.pdf)) that have been commonly employed for ribosomal translation relying on IleRS.

![Effect of in vivo post-transfer editing of TfeGly. LC-ESI-MS experiment of VW18Ile variants expressed in the absence of Ile with supplementation of 1 mM TfeGly. For translation either the wild-type IleRS (a) or the post-transfer editing deficient mutant IleRSAla10 (b) was coexpressed. The monoisotopic masses of the 5-fold charged variants of the model peptide VW18Ile, that has just one Ile position, are displayed. Calculated monoisotopic masses for Ile substitution: Val = 605.78, Leu/Ile = 608.57, TfeGly = 613.75, Met = 612.19.](oc-2016-003399_0006){#fig6}

Conclusions {#sec3}
===========

It can be assumed that no evolutionary pressure existed for the discrimination of AARSs against artificial AAs, because they were not encountered by these enzymes during evolution, suggesting that these AAs may escape translational quality control mechanisms. The lack of comprehensive studies prompted us to investigate the details of AARS misaminoacylation and editing mechanisms against artificial AAs, using TfeGly and IleRS as a model system. Fluorinated AAs such as TfeGly can increase the pharmacokinetics of peptide pharmaceuticals and display potential in the engineering of enzyme-based catalysts that are resistant to organic solvents, so-called "Teflon-proteins".^[@ref54]−[@ref56]^ Surprisingly, we observed efficient proofreading of TfeGly by IleRS, which hinders its incorporation into polypeptides. However, we demonstrated that post-transfer editing of IleRS against TfeGly-tRNA^Ile^ is also strongly defective. At the same time, rapid transfer of TfeGly to tRNA prevents significant pretransfer editing contributions to overall proofreading. Our finding that IleRS deacylation activity against TfeGly-tRNA^Ile^ is reduced to the level displayed by IleRS against its cognate product Ile-tRNA^Ile^, and at the same time prevents its misaminoacylation, was puzzling. This finding supports the assumption that the proofreading mechanism of natural AARSs is generally not very effective for artificial AAs, as a consequence of the lack of evolutionary pressure to edit these out.^[@ref57]^ Using various kinetic approaches we have provided clear evidence that the effectiveness of TfeGly-tRNA^Ile^ synthesis and subsequent TfeGly incorporation into peptides in vivo are not determined solely by the deacylation step ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}c), which is typically rapid in the case of editing substrates, but slow in the case of TfeGly. Instead, the essential factor is the ratio between the rates of TfeGly-tRNA^Ile^ dissociation and hydrolysis that determine the kinetic partitioning of the aminoacylated tRNA within the IleRS editing domain ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). In this context, both features differ remarkably for TfeGly in comparison to those known thus far for the proofreading of editing substrates such as valine. We hypothesize that the dramatically reduced dissociation rate of TfeGly-tRNA^Ile^ results from specific interactions between TfeGly and residues of the isoleucine-AARS binding pocket induced by the fluorine substituents. This effect has not been reported for tRNAs with AAs containing only elements from the cAA pool. Finally, using the IleRS variant with abolished post-transfer editing we have observed, for the first time, the ribosomal translation of TfeGly. This work expands our understanding of unnatural protein translation with the discovery and investigation of a natural editing function against artificial amino acids and demonstrates that in such cases the routinely used approach of AARS overexpression for the incorporation of artificial AAs is not always sufficient. This work provides an impulse for further systematic investigations and engineering of the translation and editing of unusual amino acids.
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ILVRSs

:   IleRS, LeuRS, ValRS

cAA

:   canonical amino acid

ncAA

:   noncanonical amino acid

AA

:   amino acid

LC-ESI-MS

:   liquid chromatography electrospray ionization mass spectrometry

CP1

:   connective polypeptide 1 (IleRS post-transfer editing domain)

AARS

:   aminoacyl-tRNA synthetase

AA-tRNA

:   aminoacyl-tRNA

Abu

:   α-aminobutyric acid

ATP

:   adenosine-5′-triphosphate

MfeGly

:   4-monofluoroethylglycine

DfeGly

:   4,4-difluoroethylglycine

TfeGly

:   4,4,4-trifluoroethylglycine

TfIle

:   5,5,5-trifluoroisoleucine

TfNVal

:   5,5,5-trifluoronorvaline

TfVal

:   4,4,4-trifluorovaline

*E. coli*

:   *Escherichia coli*

*k*~cat~

:   turnover number

*K*~M~

:   Michaelis--Menten constant

*k*~obs~

:   observed rate constant

rel

:   relative

tRNA

:   transfer RNA

mRNA

:   messenger RNA
